Fluzone (Vaccine)
Sanofi's High-Dose Influenza Vaccine Provides Superior Protection for Older Adults
The largest study of its kind, FLUNITY-HD, has demonstrated that Sanofi's high-dose influenza vaccine, Efluelda/Fluzone High-Dose, provides superior protection for older adults against hospitalization compared to standard-dose vaccines. The study, published in The Lancet, involved nearly half a million participants across several seasons and two geographic areas,